Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes? James F. O’Mahony Editorial 08 March 2019 Pages: 627 - 630
An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis Matthew FranklinJames LomasTracey Young Review Article Open access 12 February 2019 Pages: 631 - 643
Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal Lindsay ClaxtonJoanne O’ConnorRobert Hodgson Review Article 08 October 2018 Pages: 645 - 654
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Sabine E. GrimmNigel ArmstrongManuela A. Joore Review Article Open access 06 October 2018 Pages: 655 - 667
Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review Natalia Ruiz-NegrónJyothi MenonBrandon K. Bellows Systematic Review 14 January 2019 Pages: 669 - 688
Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial Aureliano Paolo FinchPatricia van VelzenJudith E. Bosmans Original Research Article Open access 19 December 2018 Pages: 689 - 699
Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States Holly GuyVicki LaskierAlexander T. Cohen Original Research Article Open access 21 December 2018 Pages: 701 - 714
EQ-5D-5L Valuation for the Malaysian Population Asrul Akmal ShafieAnnushiah Vasan ThakumarFaridah Aryani Md Yusof Original Research Article 11 December 2018 Pages: 715 - 725
Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology Istvan M. MajerJean-Gabriel CastaigneMarco Campioni Original Research Article 05 January 2019 Pages: 727 - 737
Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal Lindsay ClaxtonJoanne O’ConnorRobert Hodgson Correction 22 November 2018 Pages: 739 - 739
Correction to: Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study Matthew FranklinSarah DavisSteven Julious Correction Open access 16 February 2019 Pages: 741 - 741
